San Juan Capistrano, CA, United States of America

Andrew E Senyei

This inventor holds 39 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents, primarily in Point Of Care Diagnostics. Top assignees: Adeza Biomedical Corporation, Irori, Discovery Partners International, Inc.. Active years: 1980-2020.


% Patents Active = 89.7


 

Average Co-Inventor Count = 3.0

ph-index = 25

Forward Citations = 3,323(Granted Patents)


Location History:

  • Chicago, IL (US) (1980 - 1982)
  • Long Beach, CA (US) (1982)
  • Santa Ana, CA (US) (1992 - 1993)
  • San Juan Capistrano, CA (US) (1994 - 2002)
  • La Jolla, CA (US) (1999 - 2020)

Company Filing History:


Years Active: 1980-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Point Of Care Diagnostics
Oncofetal Fibronectin
Multiplexed Assays
Biometric Identification
Programmable Matrices
Therapeutic Agents
Pregnancy Tests
Cell Separation
39 patents (USPTO):Explore Patents

Title: **Andrew E. Senyei: Innovator in Traction Devices and Oncofetal Detection Technologies**

Introduction

Andrew E. Senyei, based in San Juan Capistrano, CA, is a notable inventor with a significant portfolio of 39 patents. His contributions span advanced medical technologies, particularly in traction devices and methods for detecting oncofetal fibronectin, showcasing his dedication to improving healthcare solutions.

Latest Patents

Among his latest innovations is the patent for a **traction apparatus and methods**, which features a brace and traction device designed for improved patient care. This device includes a forwardly open head and jaw brace that is vertically adjustable above a collar member. The design allows the brace to rotate left and right while remaining aligned with the collar member. Notably, the adjustment can be performed manually or through electronic controls operated by a microprocessor. This microprocessor not only stores user session data but also facilitates communication between the device and other personal medical devices, enhancing patient-physician interaction. Furthermore, this system can implement therapy sessions based on either physician specifications or pre-programmed settings.

In another significant innovation, he developed **methods for detecting oncofetal fibronectin**. This technology provides methods and products for identifying oncofetal fibronectin indicators in various samples, allowing for enhanced health assessments. The detection methods incorporate immunoassays and mass spectrometry techniques to evaluate health and disease status, alongside assessing disease risks.

Career Highlights

During his career, Andrew Senyei has worked with esteemed organizations including Adeza Biomedical Corporation, which focuses on women's healthcare solutions, and Irori, a company dedicated to technological advancements in medical devices. His experiences in these settings have significantly influenced his inventive initiatives.

Collaborations

Senyei has collaborated with distinguished professionals in the field, such as Michael P. Nova and Robert O. Hussa, fostering an environment of innovation and shared expertise that has likely contributed to his various successful patents and projects.

Conclusion

Andrew E. Senyei stands out as an influential inventor whose innovative medical devices and detection methods are paving the way for advancements in health technology. His work continues to impact patient care positively, exemplifying the role of inventors in transforming healthcare through innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…